Checkmate Pharmaceuticals, Inc. Contracts & Agreements
21 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (3)
- Human Resources (8)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Uncategorized (2)
- Agreement and Plan of Merger, dated as of April 18, 2022, by and among Checkmate Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., and Scandinavian Acquisition Sub, Inc (Filed With SEC on April 19, 2022)
- Executive Employment Agreement between Checkmate Pharmaceuticals, Inc. and Alan Bash, dated February 1, 2022 (Filed With SEC on February 9, 2022)
- Separation Agreement and Release between Checkmate Pharmaceuticals, Inc. and Barry Labinger, dated as of October 27, 2021 (Filed With SEC on October 27, 2021)
- Interim CEO Agreement between Checkmate Pharmaceuticals, Inc. and Alan Fuhrman, dated as of October 27, 2021 (Filed With SEC on October 27, 2021)
- Supply and Non-Exclusive License Agreement, effective as of May 6, 2021, by and between Checkmate Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on August 12, 2021)
- Description of Securities (Filed With SEC on March 29, 2021)
- Master Clinical Trial Collaboration Agreement by and between the Registrant and Bristol Myers Squibb Company, dated December 7, 2020 (Filed With SEC on March 29, 2021)
- Executive Employment Agreement, dated January 4, 2021, by and between the Company and Robert Dolski (Filed With SEC on January 5, 2021)
- Form of Underwriting Agreement (Filed With SEC on August 3, 2020)
- Specimen Common Stock Certificate (Filed With SEC on August 3, 2020)
- 2015 Stock Option and Grant Plan, as amended, and form of award agreements thereunder (Filed With SEC on August 3, 2020)
- 2020 Stock Option and Grant Plan, and form of award agreements thereunder (Filed With SEC on August 3, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on August 3, 2020)
- Form of Indemnification Agreement between the Registrant and each of its executive officers (Filed With SEC on August 3, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors (Filed With SEC on August 3, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on August 3, 2020)
- Employment Agreement between the Registrant and Barry Labinger, dated November 26, 2018, as amended on August 2, 2020, with such amendment taking effect upon the completion of... (Filed With SEC on August 3, 2020)
- Employment Agreement between the Registrant and Kleem Chaudhary, dated October 14, 2019, as amended on August 2, 2020, with such amendment taking effect upon the completion of... (Filed With SEC on August 3, 2020)
- Employment Agreement between the Registrant and Art Krieg, dated April 8, 2020, as amended on August 2, 2020, with such amendment taking effect upon the completion of this offering (Filed With SEC on August 3, 2020)
- Executive Employment Agreement by and between the Registrant and James Wooldridge, dated September 19, 2019, as amended on August 2, 2020, with such amendment taking effect upon... (Filed With SEC on August 3, 2020)
- Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated June 9, 2020 (Filed With SEC on July 17, 2020)
